GGrantIndex
← Search

STABLE NUCLEIC ACID LIPID PARTICLE (SNALP)-ENABLED SIRNA-BASED THERAPY FOR HEMORRHAGIC FEVER

$1,611,758FY2008Department of the ArmyDOD

Protiva Biotherapeutics Inc

Investigators

View source on USAspending →
STABLE NUCLEIC ACID LIPID PARTICLE (SNALP)-ENABLED SIRNA-BASED THERAPY FOR HEMORRHAGIC FEVER · GrantIndex